Structural analysis of a natural apolipoprotein A-I variant (L60R) associated with amyloidosis

Arch Biochem Biophys. 2020 May 30:685:108347. doi: 10.1016/j.abb.2020.108347. Epub 2020 Mar 16.

Abstract

The reason that determines the pathological deposition of human apolipoprotein A-I variants inducing organ failure has been under research since the early description of natural mutations in patients. To shed light into the events associated with protein aggregation, we studied the structural perturbations that may occur in the natural variant that shows a substitution of a Leucine by an Arginine in position 60 (L60R). Circular dichroism, intrinsic fluorescence measurements, and proteolysis analysis indicated that L60R was more unstable, more sensitive to cleavage and the N-terminus was more disorganized than the protein with the native sequence (Wt). A higher tendency to aggregate was also detected when L60R was incubated at physiological pH. In addition, the small structural rearrangement observed for the freshly folded variant led to the release of tumor necrosis factor-α and interleukin-1β from a model of macrophages. However, the mutant preserved both its dimeric conformation and its lipid-binding capacity. Our results strongly suggest that the chronic disease may be a consequence of the native conformation loss which elicits the release of protein conformations that could be either cytotoxic or precursors of amyloid conformations.

Keywords: Amyloidosis; Apolipopoprotein A-I; Inflammation; Protein misfolding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidogenic Proteins / chemistry
  • Amyloidogenic Proteins / genetics
  • Amyloidogenic Proteins / metabolism*
  • Amyloidosis / etiology
  • Amyloidosis / genetics
  • Apolipoprotein A-I / chemistry
  • Apolipoprotein A-I / genetics
  • Apolipoprotein A-I / metabolism*
  • Humans
  • Point Mutation
  • Protein Multimerization
  • Protein Stability
  • Protein Structure, Secondary

Substances

  • Amyloidogenic Proteins
  • Apolipoprotein A-I